Comorbidity associated with referral to pulmonary rehabilitation in people hospitalized with chronic obstructive pulmonary disease

Journal of Cardiopulmonary Rehabilitation and Prevention

Volumn 34, Issue 6, 2014, Pages 430-436

  Li, Lok Sze Katrina ^a   Caughey, Gillian ^a   Johnston, Kylie ^a  

^a UNIVERSITY OF SOUTH AUSTRALIA   (Australia)

Author keywords

Chronic obstructive pulmonary disease; Comorbidity; Pulmonary rehabilitation; Referral

Indexed keywords

AGED; ANXIETY; ARTICLE; CARDIOVASCULAR DISEASE; CHARLSON COMORBIDITY INDEX; CHRONIC OBSTRUCTIVE LUNG DISEASE; COMORBIDITY; CONTROLLED STUDY; DEPRESSION; DIABETES MELLITUS; DISEASE ASSOCIATION; DISEASE SEVERITY; FEMALE; FORCED EXPIRATORY VOLUME; GASTROINTESTINAL DISEASE; HEART ARRHYTHMIA; HOSPITAL ADMISSION; HOSPITAL UTILIZATION; HUMAN; HYPERLIPIDEMIA; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; OBSERVATIONAL STUDY; OSTEOPOROSIS; PATIENT REFERRAL; PULMONARY REHABILITATION; ARRHYTHMIAS, CARDIAC; CROSS-SECTIONAL STUDY; HOSPITALIZATION; LENGTH OF STAY; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; SEVERITY OF ILLNESS INDEX; STATISTICS AND NUMERICAL DATA;

AGED; ANXIETY; ARRHYTHMIAS, CARDIAC; COMORBIDITY; CROSS-SECTIONAL STUDIES; FEMALE; FORCED EXPIRATORY VOLUME; HOSPITALIZATION; HUMANS; HYPERTENSION; LENGTH OF STAY; MALE; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; REFERRAL AND CONSULTATION; SEVERITY OF ILLNESS INDEX;

EID: 84916638289     PISSN: 19327501     EISSN: 1932751X     Source Type: Journal    
DOI: 10.1097/HCR.0000000000000080     Document Type: Article

References (32)

1. Erbas B, Ullah S, Hyndman RJ, Scollo M, Abramson M. Forecasts of COPD mortality in Australia: 2006-2025. BMC Med Res Methodol. 2012; 12: 17-26.
2. Lozano R, Naghavi M, Foreman K, et al. Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet. 2012; 380: 2095-2128.
3. Mapel DW, Hurley JS, Frost FJ, Petersen HV, Picchi MA, Coultas DB. Health care utilization in chronic obstructive pulmonary disease - a case-control study in a health maintenance organization. Arch Intern Med. 2000; 160: 2653-2658.
4. Tkáč J, Man SFP, Sin DD. Review: systemic consequences of COPD. Ther Adv Respir Dis. 2007; 1: 47-59.
5. O'Kelly S, Smith SM, Lane S, Teljeur C, O'Dowd T. Chronic respiratory disease and multimorbidity: prevalence and impact in a general practice setting. Respir Med. 2011; 105: 236-242.
6. Sharafkhaneh A, Petersen NJ, Yu H-J, Dalal AA, Johnson ML, Hanania NA. Burden of COPD in a government health care system: a retrospective observational study using data from the US Veterans Affairs population. Int J Chron Obstruct Pulmon Dis. 2010; 5: 125-132.
7. Eisner MD, Blanc PD, Yelin EH, et al. Influence of anxiety on health outcomes in COPD. Thorax. 2010; 65: 229-234.
8. Charlson M, Pompei P, Ales K, MacKenzie C. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987; 40: 373-383.
9. Sloan KL, Sales AE, Liu C-F, et al. Construction and characteristics of the RxRisk-V: a VA-adapted pharmacy-based case-mix instrument. Med Care. 2003; 41: 761-774.
10. Lu CY, Barratt J, Vitry A, Roughead E. Charlson and Rx-Risk comorbidity indices were predictive of mortality in the Australian health care setting. J Clin Epidemiol. 2011; 64: 223-228.
11. Caughey GE, Roughead EE, Vitry AI, McDermott RA, Shakib S, Gilbert AL. Comorbidity in the elderly with diabetes: identification of areas of potential treatment conflicts. Diabetes Res Clin Pract. 2010; 87: 385-393.
12. Global Initiative for Chronic Obstructive Lung Disease. Global strategy for the diagnosis, management and prevention of chronic obstructive pulmonary disease. http://www.goldcopd.org/uploads/users/files/GOLD-Report-2013-Feb20.pdf. Published 2013. Accessed June 4, 2013.
13. Lacasse Y, Goldstein R, Lasserson TJ, Martin S. Pulmonary rehabilitation for chronic obstructive pulmonary disease. Cochrane Database Syst Rev. 2006;(4): CD003793.
14. Johnston K, Grimmer-Somers K. Pulmonary rehabilitation: overwhelming evidence but lost in translation? Physiother Can. 2010; 62: 368-373.
15. Crisafulli E, Costi S, Luppi F, et al. Role of comorbidities in a cohort of patients with COPD undergoing pulmonary rehabilitation. Thorax. 2008; 63: 487-492.
16. Crisafulli E, Gorgone P, Vagaggini B, et al. Efficacy of standard rehabilitation in COPD outpatients with comorbidities. Eur Respir J. 2010; 36: 1042-1048.
17. Johnston K, Young M, Grimmer-Somers K, Antic R, Frith PA. Frequency of referral to and attendance at a pulmonary rehabilitation program amongst patients admitted to a tertiary hospital with chronic obstructive pulmonary disease. Respirology. 2013. doi:10.1111/resp.12128. [Epub ahead of print]
18. Quan H, Sundararajan V, Halfon P, et al. Coding algorithms for defining comorbidities in ICD-9-CM and ICD-10 administrative data. Med Care. 2005; 43: 1130-1139.
19. WHO Collaborating Centre for Drug Statistics Methodology. ATC/DDD Index 2012. http://www.whocc.no/atc-ddd-index./ Accessed March 16, 2012.
20. Harris D, Hayter M, Allender S. Factors affecting the offer of pulmonary rehabilitation to patients with chronic obstructive pulmonary disease by primary care professionals: a qualitative study. Prim Health Care Res Dev. 2008; 9: 280-290.
21. Johnston K, Young M, Grimmer-Somers KA, Antic R, Frith PA. Why are some evidence-based care recommendations in chronic obstructive pulmonary disease better implemented than others? Perspectives of medical practitioners. Int J Chron Obstruct Pulmon Dis. 2011; 6: 659-667.
22. Nussbaumer-Ochsner Y, Rabe KF. Systemic manifestations of COPD. Chest. 2011; 139: 165-173.
23. Terzano C, Conti V, Stefano FD, et al. Comorbidity, hospitalization, and mortality in COPD: results from a longitudinal study. Lung. 2010; 188: 321-329.
24. Hanrahan JP, Grogan DR, Baumgartner RA, et al. Arrhythmias in patients with chronic obstructive pulmonary disease (COPD): occurrence frequency and the effect of treatment with the inhaled long-acting beta2-agonists arformoterol and salmeterol. Medicine (Baltimore). 2008; 87: 319-328.
25. Jenkins S, Hill K, Cecins NM. State of the art: how to set up a pulmonary rehabilitation program. Respirology. 2010; 15: 1157-1173.
26. Coventry P A, Bower P, Keyworth C, et al. The effect of complex interventions on depression and anxiety in chronic obstructive pulmonary disease: systematic review and meta-analysis. PloS One. 2013; 8: e60532.
27. Berry MJ, Rejeski WJ, Adair NE, Zaccaro D. Exercise rehabilitation and chronic obstructive pulmnonary disease stage. Am J Respir Crit Care Med. 1999; 160: 1248-1253.
28. Ramachandran K, McCusker C, Connors M, Zuwallack R, Lahiri B. The influence of obesity on pulmonary rehabilitation outcomes in patients with COPD. Chron Respir Dis. 2008; 5: 205-209.
29. Sava F, Laviolette L, Bernard S, Breton M-J, Bourbeau J, Maltais F. The impact of obesity on walking and cycling performance and response to pulmonary rehabilitation in COPD. BMC Pulm Med. 2010; 10: 55. http://www.biomedcentral.com/1471-2466/10/55.
30. Flegal KM, Carroll MD, Kit BK, Ogden CL. Prevalence of obesity and trends in the distribution of body mass index among US adults, 1999-2010. JAMA. 2012; 307: 491-497.
31. Walls HL, Magliano DJ, Stevenson CE, et al. Projected progression of the prevalence of obesity in Australia. Obesity (Silver Spring). 2012; 20: 872-878.
32. Garcia-Aymerich J, Lange P, Benet M, Schnohr P, Anto JM. Regular physical activity reduces hospital admission and mortality in chronic obstructive pulmonary disease: a population based cohort study. Thorax. 2006; 61: 772-778.